AI assistant
HARVARD BIOSCIENCE INC — Director's Dealing 2012
Jan 27, 2012
34975_dirs_2012-01-27_2150554b-6854-4b97-a933-6f03f25269a1.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 5 — Annual Statement of Changes in Beneficial Ownership
Issuer: HARVARD BIOSCIENCE INC (HBIO)
CIK: 0001123494
Period of Report: 2011-12-31
Reporting Person: GRAZIANO CHANE (Director, Chief Executive Officer, 10% Owner)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2011-04-13 | Common Stock | G | 1000000 | — | Disposed | 2340878 | Direct |
| 2011-05-14 | Common Stock | G | 500000 | — | Disposed | 2340878 | Direct |
Footnotes
F1: Purchase price is not applicable as this transaction was a bona fide gift.
F2: Purchase price is not applicable as this transaction was a bona fide gift.
F3: Includes (a) a deferred stock award of 100,200 restricted stock units which vest in equal installments on Jan 1, 2012, Jan 1, 2013 and Jan 1, 2014; (b) a deferred stock award of 53,750 restricted stock units which vest in equal installments on Jan 1, 2012, Jan 1, 2013, Jan 1, 2014 and Jan 1, 2015; and (c) 2,186,928 shares of common stock held by Mr. Graziano.